Expert panel to consider SII's emergency use approval for Covid-19 vaccine

Subject Expert Committee (SEC) of Drugs Controller of India is set to hold a meeting to consider Serum Institute of India's application for emergency use approval of its Covid-19 vaccine, says a government official, according to news agency ANI.

Subject Expert Committee (SEC) of Drugs Controller of India to take a meeting to consider Serum Institute of India's application for emergency use approval of its COVID19 vaccine, says a government official

— ANI (@ANI) December 30, 2020

This comes after the United Kingdom gave its nod to the Oxford-AstraZeneca vaccine on Wednesday as it battles a major winter surge driven by a new, highly contagious variant of the virus.